Drug intelligence / Profile preview

Gaizhonggai

Development stage: Unknown
Lead developer: Harbin Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

**Gaizhonggai** is a well-known Chinese brand of calcium supplements produced by Harbin Pharmaceutical Group Co., Ltd., primarily available as oral liquids (e.g., calcium lactate oral liquid) and high-calcium tablets. These formulations provide elemental calcium (e.g., 500mg per 2.5g tablet) to support bone health, prevent calcium deficiency, and address nutritional needs, often marketed as over-the-counter (OTC) products in China. The brand is part of Harbin Pharmaceutical's portfolio of healthcare and nutritional supplements, distributed widely through online and offline channels.[1][2][3][7]

Brand names: Gaizhonggai
Other names: GaiZhongGai

Targets

CaSR (Extracellular calcium-sensing receptor)

Beyond the preview

Go deeper on Gaizhonggai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gaizhonggai.

Explore the full profile